Article
Tumor Whole-Genome Sequencing for Prediction of Venous Thromboembolism in Patients With Metastasized Solid Cancer.
Circulation. Genomic and precision medicine - 1 Jun 2026
Mulder Frits I, Guman Noori A M, van Riet Job, van Geffen Roos J, van Haaps Thijs F, Hovsepjan Vahram, van Laarhoven Hanneke W M, Cirkel Geert A, de Vos Filip Y F L, Westgeest Hans M, Beerepoot Laurens V, de Vos-Geelen Judith, Labots Mariette, Hamberg Paul, Vulink Annelie J E, Los Maartje, Zwinderman Aeilko H, Robbrecht Debbie G J, de Jonge Maja J A, Büller Harry R, Kamphuisen Pieter W, Ferwerda Bart, Steeghs Neeltje, van Es Nick
Abstract excerpt
BACKGROUND: International guidelines suggest prophylactic anticoagulation for patients with cancer at high risk of venous thromboembolism (VTE). Here, we evaluated whether tumor whole-genome sequencing data may improve the selection of high-risk patients. METHODS: In a pan-cancer cohort of 3087 patients, associations of candidate clinical predictors, the germline extended 297-single nucleotide polymorphism...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
